Last Updated:
Access Report
Name Designation Appointment Date Status
Vijai Kumar Asthana

Appointed as Director since September 2018

 Director 30-Sep-2018 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Ranvijay Singh

Appointed as Director since September 2018

 Director 30-Sep-2018 Current
Neeraj Shukla

Appointed as Director since September 2018

 Director 30-Sep-2018 Current

People Timeline

Explore the timeline of key personnel in Myrtle Pharmaceutical Private Limited's leadership journey.

Contact Details
  • Address House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi Delhi, 110082, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110082
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Myrtle Pharmaceutical Private Limited?
You can contact Myrtle Pharmaceutical Private Limited through their registered address at House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi Delhi, 110082, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Myrtle Pharmaceutical Private Limited?
The current directors of Myrtle Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • VIJAI KUMAR ASTHANA
  • RANVIJAY SINGH
  • NEERAJ SHUKLA
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available